Haematological malignancies (blood cancers)

SNIPR Biome has dosed the first patient in its Phase 1b trial of SNIPR001, a CRISPR-CAS-armed bacteriophage therapy that represents a new frontier in...

Haematological malignancies (blood cancers)

B-cell Non-Hodgkin Lymphoma, NHL, (NCT06321289)
Sponsors:
Chinese PLA General Hospital

IND Enabling

Phase I

Phase II

Phase III

Relapsed/Refractory Hematologic Malignancies (NCT06492304)
Sponsors:
CRISPR Therapeutics

IND Enabling

Phase I

Phase II

Phase III

Relapsed or Refractory Acute Lymphocytic Leukemia, ALL, (NCT06481735)
Sponsors:
Chinese PLA General Hospital

IND Enabling

Phase I

Phase II

Phase III

Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, NHL, (NCT05741359)
Sponsors:
Bioray Laboratories

IND Enabling

Phase I

Phase II

Phase III

Large B-cell lymphoma, LBCL, (NCT06500273)
Sponsors:
Allogene Therapeutics

IND Enabling

Phase I

Phase II

Phase III

Relapsed or Refractory B-Cell Malignancies, (NCT05336409)
Sponsors:
Century Therapeutics, Inc.

IND Enabling

Phase I

Phase II

Phase III

B-Cell Non-Hodgkin Lymphoma, NHL, (NCT06014073)
Sponsors:
Chinese PLA General Hospital

IND Enabling

Phase I

Phase II

Phase III

B-Cell Non-Hodgkin Lymphoma, NHL, (NCT05631912)
Sponsors:
Chinese PLA General Hospital

IND Enabling

Phase I

Phase II

Phase III